Faster response to new virus variants
DZIF-HZI team developed a method to quickly and reliably identify mutations responsible for immune escape
Transmission electron micrograph of SARS-CoV-2 virus particles (orange) isolated from a patient.
Viruses are masters at disguise. When they are pushed too far by our immune system, they send new virus variants into play that are no longer recognized by immune cells. They escape our immune system by mutating the virus structures that are recognized by antibodies. In order to adapt vaccines to new circulating virus variants as promptly as possible, it is first necessary to find out which among the numerous mutations are actually responsible for the immune escape of a new virus variant. Researchers at the Helmholtz Centre for Infection Research (HZI) and the German Center for Infection Research (DZIF), in collaboration with the Hannover Medical School (MHH), have developed a method called reverse mutational scanning that can be used to detect such mutations quickly and reliably. The study has been published in the journal Nature Communications.
Viruses have all kinds of tricks up their sleeves. It often does not take long for pathogens such as SARS-CoV-2 to adapt and escape immune recognition. Viruses with mutations, that evade immune recognition more efficiently than the original virus will have a selective advantage and prevail over time, increasingly dominating the infection landscape. “If the new virus variant can successfully escape the immune response, it is no longer sufficient to have recovered from one of the previous variants or to have been vaccinated with a previously effective vaccine,” says Prof. Luka Cicin-Sain, head of the department “Viral Immunology” at the HZI and a scientist in the "Infections in the Immunocompromised Host" research area of the German Center for Infection Research (DZIF). “With vaccine development, we are always playing catch-up with the spread of new escape variants. That's the very nature of virus evolution. Nevertheless, we need to outsmart the viruses and reduce their advantages, both for currently circulating ones and for those that will be around in future pandemics.”
A swift identification of mutations that are crucial for the immune escape enable the rapid adaptation of vaccines to new virus variants. In their current study, the team led by Cicin-Sain presents a promising new approach for doing just that. It is based on a previously established method called mutational scanning: Each mutation found in the new variant is introduced separately into the original virus to generate a library of virus mutants. The effects of each individual mutation can thus be defined by comparing the mutants from the library to the original and to the new virus variant. However, in their study, the HZI researchers modified the procedure by introducing the mutations one by one into the new virus variant to make it resemble the original virus at each position. Hence, they used the methodology in reverse, which is why they called it reverse mutational scanning.
How reverse mutational scanning works
What exactly is the process behind reverse mutational scanning and how did the research team go about it? To test their new approach, the scientists examined viral variants of SARS-CoV-2 as an example. They wanted to find out which of the 33 mutations that distinguish the BA.2.86 virus variant from the original BA.2 variant are responsible for immune escape.
Using advanced genetic methods, the researchers produced so-called pseudoviruses, which use the SARS-CoV-2 spike protein to enter cells, but are unable to replicate and are therefore harmless to humans and the environment. The researchers started from the new virus variant with immune escape, i.e. BA.2.86. “To find out which mutations are responsible for the immune escape of this virus variant, we created various pseudoviruses in which one of the 33 different mutations was reversed, in the direction of the original virus BA.2,” explains Dr. Najat Bdeir, a scientist in the department “Viral Immunology” at the HZI and first author of the study. In extensive cell experiments, the researchers then investigated how well the respective pseudoviruses could be combated by immune cells. To do this, they used samples “from real life”. “For the study, we were able to provide blood sera from a cohort of 40 people working in the healthcare sector,” says Prof. Georg Behrens from the Department of Rheumatology and Immunology at Hannover Medical School. ”The participants had been vaccinated multiple times, including with the then-current vaccine that was effective against Omicron XBB.1.5,” adds Behrens, who is deputy coordinator of the DZIF research area "HIV".
“Backwards takes us forwards!"
Using reverse mutational scanning, the researchers identified that three mutations in the spike protein were responsible for immune escape. But why is it important to start with the new virus variant and reverse the individual mutations, thus applying mutational scanning in “reverse”? “This is important because our immune cells are very diverse. They can make antibodies that bind to different parts on the virus and thus block the infection process,” explains Cicin-Sain. ”If we start from the original variant and insert a mutation in an area that is actually recognized by antibodies, there is a high probability that antibodies binding to another part of the virus will still recognize and neutralize the virus. The actual contribution of the mutation to immune escape cannot be adequately detected in this way. So we have to start from the new variant and work backwards from there – backwards takes us forwards here!”
The researchers hope that their new method can also advance and accelerate future vaccine development. With reverse mutational scanning, other viruses and their variants could be analyzed for mutations responsible for immune escape. “It would also be conceivable to use this new method to train machine learning and AI models to predict which potential mutations of a virus could lead to immune escape,” says Cicin-Sain. ”If we could produce vaccines based on pre-adapted vaccines, we would be faster than the virus!”
In addition to Luka Cicin-Sain's department “Viral Immunology”, Prof. Wulf Blankenfeldt's department “Structure and Function of Proteins” of HZI was also involved in this study. Scientists from the Centre for Individualised Infection Medicine (CiiM), German Primate Center – Leibniz Institute for Primate Research and the Leibniz Institute DSMZ – German Collection of Microorganisms and Cell Cultures also contributed with their expertise to this study.
Source: Press release of the Helmholtz Centre for Infection Research (HZI). Text: Nicole Silbermann
